Clive S. Zent, M.D.

Clive S. Zent, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Office: (585) 273-3258
Administrative: (585) 273-3258
Fax: (585) 276-0350

Journal Articles

Showing all 125 journal articles available.

2015 Mar 17
Zent CS, Call TG, Bowen DA, Conte MJ, LaPlant BR, Witzig TE, Ansell SM, Weiner GJ. "Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates." Leukemia & lymphoma. 2015 Mar 17; :1-6. Epub 2015 Mar 17.
2015 Feb
Bowen DA, Rabe KG, Schwager SM, Slager SL, Call TG, Viswanatha DS, Zent CS. "Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication." Leukemia & lymphoma. 2015 Feb; 56(2):311-4. Epub 2014 Jun 25.
2015
Stilgenbauer S, Furman RR, Zent CS. "Management of chronic lymphocytic leukemia." American Society of Clinical Oncology educational book. 2015 :164-75.
2014 Nov
Barr, PM; Zent, CS. "The ABC of CLL: Etiology of cytopenias is important in staging and management". Leuk Lymphoma. 2014; 55: 12-19.
2014 Sep
Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, Schwager SM, Call TG, Viswanatha DS, Zent CS. "Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma." Leukemia & lymphoma. 2014 Sep; 55(9):2079-84. Epub 2014 Feb 17.
2014 Jul 1
Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL. "Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines." Cancer. 2014 Jul 1; 120(13):2000-5. Epub 2014 Apr 07.
2014 Jul
Zent CS, Taylor RP, Lindorfer MA, Beum PV, LaPlant B, Wu W, Call TG, Bowen DA, Conte MJ, Frederick LA, Link BK, Blackwell SE, Veeramani S, Baig NA, Viswanatha DS, Weiner GJ, Witzig TE. "Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells." American journal of hematology. 2014 Jul; 89(7):757-65. Epub 2014 Apr 26.
2014 Apr
Slager SL, Zent CS. "Genetic risk of chronic lymphocytic leukemia: a tale of two cities." Leukemia & lymphoma. 2014 Apr; 55(4):735-6. Epub 2013 Nov 01.
2014 Feb 15
Baig NA, Taylor RP, Lindorfer MA, Church AK, LaPlant BR, Pettinger AM, Shanafelt TD, Nowakowski GS, Zent CS. "Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia." The Journal of immunology : official journal of the American Association of Immunologists. 2014 Feb 15; 192(4):1620-9. Epub 2014 Jan 15.
2014
Zent CS, Burack WR. "Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53." Hematology. 2014 2014(1):119-24. Epub 2014 Nov 18.
2014
Barr PM, Zent CS. "Infection in chronic lymphocytic leukemia: parsimony has its limits." Leukemia & lymphoma. 2014 55(12):2683-4. Epub 2014 May 16.
2013 Nov 1
Shanafelt T, Lanasa MC, Call TG, Beaven AW, Leis JF, LaPlant B, Bowen D, Conte M, Jelinek DF, Hanson CA, Kay NE, Zent CS. "Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)." Cancer. 2013 Nov 1; 119(21):3788-96. Epub 2013 Aug 06.
2013 Nov
Greipp, PT; Smoley, SA; Viswanatha, DS; Frederick, LS; Rabe, KG; Sharma, RG; Slager, SL; Van Dyke, DL; Shanafelt, TD; Tschumper, RC; Zent, CS. "Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis". Br J Haematol. 2013; 163(3): 326-33.
2013 Sep
Charbonneau B, Wang AH, Maurer MJ, Asmann YW, Zent CS, Link BK, Ansell SM, Weiner GJ, Ozsan N, Feldman AL, Witzig TE, Cunningham JM, Dogan A, Habermann TM, Slager SL, Novak AJ, Cerhan JR. "CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis." Cancer immunology, immunotherapy : CII. 2013 Sep; 62(9):1475-84. Epub 2013 Jun 28.
2013 Sep
Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W, Leis JF, Schwager SM, Hanson CA, Macon WR, Kay NE, Slager SL, Shanafelt TD. "Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients." British journal of haematology. 2013 Sep; 162(6):774-82. Epub 2013 Jul 11.
2013 Jul
Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ. "A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma." American journal of hematology. 2013 Jul; 88(7):589-93. Epub 2013 Jun 12.
2013 Jun 10
Gonsalves WI, Zent CS, Pulido JS, Patnaik MM. "Visual loss in early-stage chronic lymphocytic leukemia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Jun 10; 31(17):e280-2. Epub 2013 May 06.
2013 May 16
Shanafelt TD, Ramsay AG, Zent CS, Leis JF, Tun HW, Call TG, LaPlant B, Bowen D, Pettinger A, Jelinek DF, Hanson CA, Kay NE. "Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)." Blood. 2013 May 16; 121(20):4137-41. Epub 2013 Mar 14.
2013 May
Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A. "Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma." American journal of hematology. 2013 May; 88(5):375-8. Epub 2013 Mar 19.
2013 Mar
Zent, CS; Wu, W; Bowen, DA; Hanson, CA; Pettinger, AM; Shanafelt, TD; Kay, NE; Leis, JF; Call, TG. "Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphpocytic leukemia with alemtuzumab and rituximab". Leuk Lymphoma. 2013; 54(3): 476-82.
2013 Jan
Shanafelt, TD; Call, TG; Zent, CS; Leis, JF; LaPlant, B; Bowen, DA; Roos, M; Laumann, K; Ghosh, AK; Lesnick, C; Lee, MJ; Yang, CS; Jelinek, DF; Erlichman, C; Kay, NE. "Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphpocytic leukemia". Cancer. 2013; 119(2): 363-70.
2012 Nov
Baig NA; Taylor RP; Lindorfer MA; Church AK; LaPlant Br; Pavey ES; Nowakowski GS; Zent CS. "Complement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement". Leuk Lymphoma. 2012; 53(11): 2218-27.
2012 Sep
Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; WeinerGJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR. "Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma". Am J Hematol. 2012; 87(9): 880-5.
2012 Aug
Taylor RP; Lindorfer MA; Zent CS. "Anti-CD20 antibody therapy for B-cell lymphomas". N Engl J Med. 2012; 367(9): 876-7.
2012 Apr
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG. "Hematologist/oncologist disease-specific expertise and survival: lessions from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)". Cancer. 2012; 118(7): 1827-37.
2012 Mar
Gustafson MP; Abraham RS; Lin Y; Wu W; Gastineau DA; Zent CS; Dietz AB. "Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)". Br J Haematol. 2012; 156(5): 674-6.
2012 Feb
Zent CS; Smith BJ; Ballas ZK; Wooldridge JE; Link BK; Call TG; Shanafelt; TD; Bowen DA; Kay NE; Witzig TE; Weinier GJ. "Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia". Leuk Lymphoma. 2012; 53(2): 211-7.
2012 Feb
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Schwager SM; Leis JF; Jelinek DF; Slager SL; Hanson CA. "Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population". Leukemia. 2012; 26(2): 373-6.
2012 Feb
Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Schwager SM, Leis JF, Jelinek DF, Slager SL, Hanson CA. "Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population." Leukemia. 2012 Feb; 26(2):373-6. Epub 2011 Aug 12.
2012
Lindorfer MA; Wiestner A; Zent CS; Taylor RP. "Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?". Oncoimmunology. 2012; 1(6): 959-61.
2012
Zent CS. "Improving quality of life in chronic lymphocytic leukemia". Leuk Lymphoma. 2012; 53(7): 1247-8.
2011 Oct
Zent CS. "Multi-parameter prognostication in chronic lymphocytic leukemia". Leuk Lymphoma. 2011; 52(10): 1823-4.
2011 Oct
Mraz M; Zent CS; Church AK; Jelinek DF; Wu X. "Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin alpha-4-beta-1 (VLA-4) with natalizumab can overcome this resistance". Br J Haematol. 2011; 155(1): 53-64.
2011 Sep
Maurer MJ; Cerhan JR; Katzmann JA; Link BK; Allmer C; Zent CS; Call TG; Rabe KG; Hanson CA; Kay NE; Slager SL; Witzig TE; Shanafelt TD. "Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia". Blood. 2011; 118(10): 2821-6.
2011 Aug
Zent CS; Kay NE. "Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach". Leuk Lymphoma. 2011; 52(8): 1425-34.
2011 Jul
Chen D; Kettering RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS. "A case of hairy cell leukemia with CCND1-IGH translocation: indolent non-nodal mantle cell lymphoma revisited". Am J Surg Pathol. 2011; 35(7): 1080-4.
2011 Jun
Zent CS; Polliack A; Tadmor T. "FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes". Leuk Lymphoma. 2011; 52(6): 946-7.
2011 Feb
Shanafelt TD; Drake MT; Maurer MJ; Allmer C; Rabe KG; Slager SL; Weiner GH; Call TG; Link BK; Zent CS; Kay NE; Hanson CA; Witzig TE; Cerhan JR. "Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia". Blood. 2011; 117(5): 1492-8.
2011
Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF. "Differentiation of chronic lymphocytic leukemia B-cells into immunoglobulin secreting cells decreases LEF-1 expression". PLoS One. 2011; 6(10): e26056.
2010 Dec
Shanafelt T; Zent C; Byrd J; Erlichman C; LaPlant B; Ghosh A; Call T; Villalona-Calero M; Jelinek D; Bowen D; Laumann K; Wu W; Hanson C; Kay N. "Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(12): 2222-9.
2010 Oct 15
Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, Schwager SM, Bowen DA, Slager SL, Hanson CA, Call TG. "Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia." Cancer. 2010 Oct 15; 116(20):4777-87.
2010 Oct
Zent CS. "Cell-mediated immunity in chronic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(10): 1775-6.
2010 Oct
Shanafelt TD; Rabe KG; Kay NE; Zent CS; Jelinek DF; Reinalda MS; Schwager SM; Bowen DA; Slager SL; Hanson CA; Call TG. "Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia". Cancer. 2010; 116(20): 4777-87.
2010 Sep
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PG; Zent CS. "CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma". Leuk Res. 2010; 34(9): 1235-8.
2010 Jul
Shanafelt, TD; Rabe, KG; Kay, NE; Zent, CS; Call, TG; Slager, SL; Bowen, DA; Schwager, SM; Nowakowski, GS. "Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chornic lymphocytic leukemia". Leuk Lymphoma. 2010; 51(7): 1233-40.
2010 Jul
Zent CS. "Chronic Lymphocytic Leukemia in the Elderly: Who Should be Treated?". Am Soc Clin Oncol Ed. 2010; : 268-71.
2010 Jun
Bauer PR; Zent CS; Aubry MC; Ryu JH. "Recurrent fevers, cough, and pulmonary opacities in a middle-aged man". Chest. 2010; 137(6): 1465-9.
2010 May
Zent CS; LaPlant BR; Johnston PB; Call TG; Habermann TM; Micallef IN; Witzig TE. "The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation". Cancer. 2010; 116(9): 2201-7.
2010 May
Kay NE; Wu W; Kabat B; LaPlant B; Lin TS; Byrd JC; Jelinek DF; Grever MR; Zent CS; Call TG; Shanafelt TD. "Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia". Cancer. 2010; 116(9): 2180-7.
2010 May
Zent CS. "Time to test CLL p53 function". Blood. 2010; 115(21): 4154-5.
2010 Apr
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager RM; Reinalda MS; Rabe KG; Slager SL; Zent CS. "Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone". Leuk Lymphoma. 2010; 51(4): 620-7.
2010 Mar
Zent CS; Kay NE. "Autoimmune complications in chronic lymphocytic leukaemia (CLL)". Best Pract Res Clin Haematol. 2010; 23(1): 47-59.
2010 Feb
Van Dyke DL; Shanafelt TD; Call TG; Zent CS; Smoley SA; Rabe KG; Schwager SM; Sonbert JC; Slager SL; Kay NE. "A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia". Br J Haematol. 2010; 148(4): 544-50.
2010 Feb
Zent CS; Van Dyke DL. "Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications". Leuk Lymphoma. 2010; 51(2): 186-7.
2010
Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS. "CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity". Cytometry B Clin Cytom. 2010; 58(Suppl 1): S35-41.
2009 Nov
Ding W; Nowakowski GS; Knox TR; Boysen JC; Maas ML; Schwager SM; Wu W; Wellik LE; Dietz AB; Ghosh AK; Secreto CR; Medina KL; Shanafelt TD; Zent CS; Call TG; Kay NE. "Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression". Br J Haematol. 2009; 147(4): 471-83.
2009 Oct 15
Pardanani A, Tefferi A, Litzow MR, Zent C, Hogan WJ, McClure RF, Viswanatha D. "Chronic myeloid leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis." Blood. 2009 Oct 15; 114(16):3502-3.
2009 Sep
Shanafelt TD; Byrd JC; LaPlant B; Zent CS; Call T; Secreto C; Grever MR; Lin TS; Kay NE. "Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia". Br J Haematol. 2009; 146(6): 660-4.
2009 Aug
Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL. "Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis". Leuk Lymphoma. 2009; 50(8): 1261-8.
2009 Aug
Shanafelt TD; Call TG; Zent CS; LaPlant B; Bowen DA; Roos M; Secreto CR; Ghosh AK; Kabat BF; Lee MJ; Yang CS; Jelinek DF; Erlichman C; Kay NE. "Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(23): 3808-14.
2009 Aug
Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA. "Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(24): 3959-63.
2009 Jun
Zent CS; Shanafelt T. "Management of autoimmune cytopenia complicating chronic lymphocytic leukemia". Leuk Lymphoma. 2009; 50(6): 863-4.
2009 Apr
Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE. "Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia". J Clin Oncol. 2009; 27(11): 1844-9.
2009 Apr
Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA. "B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome". Blood. 2009; 113(18): 4188-96.
2009 Feb
Shanafelt TD; Bowen DA; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Tun H; Sloan JA; Call TG. "The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia". Leuk Res. 2009; 33(2): 263-70.
2009 Jan 15
Awan FT, Kay NE, Davis ME, Wu W, Geyer SM, Leung N, Jelinek DF, Tschumper RC, Secreto CR, Lin TS, Grever MR, Shanafelt TD, Zent CS, Call TG, Heerema NA, Lozanski G, Byrd JC, Lucas DM. "Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab." Blood. 2009 Jan 15; 113(3):535-7. Epub 2008 Nov 13.
2009 Jan
Shanafelt TD; Jenkins G; Call TG; Zent CS; Slager S; Bowen DA; Schwager S; Hanson CA; Jelinek DF; Kay NE. "Validation of a new prognostic index for patients with chronic lymphocytic leukemia". Cancer. 2009; 115(2): 363-72.
2008 Dec
Zent CS; Secreto CR; LaPlant BR; Bone ND; Call TG; Shanafelt TD; Jelinek DF; Tschumper RC; Kay NE. "Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab". Leuk Res. 2008; 32(12): 1849-56.
2008 Oct
Zent CS; Call TG' Shanafelt TD; Tschumper RC; Jelinek DF; Bowen DA; Secreto CR; Laplant BR; Kabat BF; Kay NE. "Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab". Cancer. 2008; 113(8): 2110-8.
2008 Sep
Shanafelt TD; Kay NE; Cell TG; Zent CS; Jelinek DF; LaPlant B; Morice WG; Hanson CA. "MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count , greater than or equal to 5 x 10e9/L but a B-cell lymphocyte count less than or equal to 5 x 10e9/L?". Leuk Res. 2008; 32(9): 1458-61.
2008 Aug
Holtan SG, Porrata LF, Colgan JP, Zent CS, Habermann TM, Markovic SN. "mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)." American journal of hematology. 2008 Aug; 83(8):688-9.
2008 May
Palmer S; Hanson CA; Zent CS; Porrata LF; Laplant B; Geyer SM; Markovic SN; Call TG; Bowen DA; Jelinek DF; Kay NE; Shanafelt TD. "Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia". Br J Haematol. 2008; 141(5): 607-14.
2008 May
Hogan WJ; Zent CS. "Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma". Leuk Lymphoma. 2008; 49(5): 835-6.
2008 May
Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL. "The prognostic significant of cytopenia in chronoc lymphocytic leukaemia/small lymphocytic lymphoma". Br J Haematol. 2008; 141(5): 615-21.
2008 May
Hogan WJ, Zent CS. "Stem cell transplant for chronic lymphocytic leukemia/small lymphocytic lymphoma." Leukemia & lymphoma. 2008 May; 49(5):835-6.
2008 Mar
Shanafelt TD; Geyer SM; Bone ND; Tschumper RC; Witzig TE; Nowakowski GS; Zent CS; Call TG; Laplant B; Dewald GW; Jelinek DF; Kay NE. "CD49d expression is an independent predictor of overall survival i npatients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential". Br J Haematol. 2008; 140(5): 537-46.
2008 Feb
Zent CS. "The role of alemtuzumab in the treatment of chronic lymphocytic leukemia." Leukemia & lymphoma. 2008 Feb; 49(2):175-6.
2008 Jan
Thurmes P; Call T; Slager S; Zent C; Jenkins, G; Schwager S; Bowen, D; Kay NE; Shanafelt T. "Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia". Leuk Lymphoma. 2008; 49(1): 49-56.
2008 Jan
Tschumper RC; Geyer SM; Campbell ME; Kay NE; Shanafelt TD; Zent CS; Nowakowski GS; Call TG; Dewald GW; Jelinek DF. "Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients". J Clin Invest. 2008; 118(1): 306-15.
2007 Dec
Bowen DA; Call TG; Jenkins GD; Zent CS; Schwager SM; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD. "Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features". Leuk Lymphoma. 2007; 48(12): 2412-7.
2007 Dec
Browning RL; Geyer SM; Johnson AJ; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Zent CS; Bone ND; Dewald GW; Lin TS; Heerema NA; Gever MR; Kay NE; Byrd JC; Lucas DM. "Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia". Leuk Res. 2007; 49(1): 49-56.
2007 Nov
Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD. "Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia". Br J Haematol. 2007; 139(3): 398-404.
2007 Oct
Shanafelt TD; Bowen D; Venkat C; Slager SL; Zent CS; Kay NE; Reinalda M; Sloan JA; Call TG. "Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients". Br J Haematol. 2007; 139(2): 255-64.
2007 Sep
Zent CS; Kay NE. "Chronic lymphocytic leukemia: biology and current treatment". Curr Oncol Rep. 2007; 9(5): 345-52.
2007 Jun
Shanafelt TD; Lin T; Geyer SM; Zent CS; Leung N; Kabat B; Bowen D; Grever MR; Byrd JC; Kay NE. "Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia". Cancer. 2007; 109(11): 2291-8.
2007 Apr
Ding W; Zent CS. "Diagnosis and management of autoimmune complications of chronic lymphocytic leukemia/small lymphocytic lymphoma". Clin Adv Hematol Oncol. 2007; 5(4): 257-61.
2007 Apr
Nowakowski GS; Hoyer JD; Shanafelt, TD; Geyer, SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE. "Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test". Mayo Clin Proc. 2007; 82(4): 449-53.
2007 Feb
Rockacy J; Viozzi CF; Zent CS. "Mantle cell lymphoma presenting as a slowly enlarging lesion of the floor of mouth in a healthy 72 year old: report of a case". J Oral Maxillofac Surg. 2007; 65(2): 333-7.
2007 Jan
Kay NE; Geyer SM; Call TG; Shanafelt TD; Zent CS; Jelinek DF; Tschumper R; Bone ND; Dewald GW; Lin TS; Heerema NA; Smith L; Grever MR; Byrd JC. "Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia". Blood. 2007; 109(2): 405-11.
2006 Dec
Zent CS; Polliack A. "Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis". Leuk Lymphoma. 2006; 47(12): 2433-4.
2006 Oct
Zent CS. "Chronic B-cell lymphoproliferative disorders: how many diseases?". Leuk Lymphoma. 2006; 47(10): 2006-7.
2006 Oct
Shanafelt TD; Witzig TE; Fink SR; Jenkins RB; Paternoster SF; Smoley SA; Stockero KJ; Nast DM; Flynn HC; Tschumper RC; Geyer S; Zent CS; Call TG; Jelinek DF; Kay NE. "Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia". J Clin Oncol. 2006; 24(28): 4634-41.
2006 Sep
Lee HB; Pulido JS; Buettner H; Salomao D; Zent CS; Link TP. "Intravascular B-cell lymphoma (angiotropic lymphoma) with choroidal involvement". Arch Ophthalmol. 2006; 124(9): 1357-9.
2006 Sep
Zent CS; Call TG; Hogan WJ; Shanafelt TD; Kay NE. "Update on risk-stratified management for chronic lymphocytic leukemia". Leuk Lymphoma. 2006; 47(9): 1738-46.
2006 Sep
Shanafelt TD; Byrd JC; Call TG; Zent CS; Kay NE. "Narrative review: initial management for chronic lymphocytic leukemia". Ann Intern Med. 2006; 145(6): 435-47.
2006 Aug
Nora EH; Hamacher KL; Zent CS; Ghosh AK. "Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes". South Med J. 2006; 99(8): 876-9.
2006 Aug
Zent CS. "Autoimmunity and chronic lymphocytic leukemia". Leuk Lymphoma. 2006; 47(8): 1443-4.
2006 Jul
Osborn NK; Ustundag Y; Zent CS; Wiesner RH; Rosen CB; Narayanan Menon KV. "Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature". Am J Transplant. 2006; 6(7): 1743-5.
2006 Jun
Fink SR; Smoley SA; Stockero KJ; Paternoster SF; Thorland EC; Van Dyke DL; Shanafelt TD; Zent CS; Call TG; Kay NE; Dewald GW. "Loss of TP53 due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia". Cancer Genet Cytogenet. 2006; 167(2): 177-81.
2006 Apr
Stockero KJ; Fink SR; Smoley SA; Paternoster SF; Shanafelt TD; Call TG; Zent CS; Van Dyke DL; Kay NE; Dewald GW. "Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia". Cancer Genet Cytogenet. 2006; 166(2): 152-6.
2005 Dec
Shanafelt TD; Lee YK; Call TG; Nowakowski GS; Dingli D; Zent CS; Kay NE. "Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies". Leuk Res. 2005; 30(6): 707-12.
2005 Jul
Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS. "Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia". Br J Haematol. 2005; 130(1): 36-42.
2005 Jan
Nowakowski GS, Call TG; Morice WG; Kurtin PJ; Cook RJ; Zent CS. "Clinical significance of monoclonal B cells in cerebrospinal fluid". Cytometry B Clin Cytom. 2005; 63(1): 23-7.
2004 Sep
Zent CS; Kay NE. "Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia". Curr Oncol Rep. 2004; 6(5): 348-54.
2004 May
Zent CS; Chen JB; Kurten RC; Kaushal GP; Lacy HM; Schichman SA. "Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium". Leuk Res. 2004; 28(5): 495-507.
2004 Mar
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS. "Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death". Leuk Lymphoma. 2004; 45(3): 507-13.
2004 Feb
Zent CS; Kay NE. "Update on monoclonal antibody therapy in chronic lymphocytic leukemia". Clin Adv Hematol Oncol. 2004; 2(2): 107-13.
2004
Kohli M; Zent C; Hutchins LF; Safar M; Dotson P; Mehta P. "The academic hematology-oncology firm: a model for postgraduate cancer education". J Cancer Educ. 2004; 19(1): 45-9.
2003 Sep
Kyasa MJ; Parrish RS; Schichman SA; Zent CS. "Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma". Am J Hematol. 2003; 74(1): 1-8.
2003 Sep
Zent CS; Zhan FG; Schichman SA; Bumm KHW; Lin P; Chen JB; Shaughnessy JD. "The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype". Leuk Res. 2003; 27(9): 765-74.
2002 Jan
Kohli M; Fink LM; Spencer JH; Zent CS. "Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer". Blood Coagul Fibrinolysis. 2002; 13(1): 1-5.
2002
Monson T; Schichman SA; Zent CS. "Linezolid-induced pure red blood cell aplasia". Clin Infect Dis. 2002; 35(3): E29-31.
2001 Dec
Joseph L; Scott MA; Schichman SA; Zent CS. "Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma". Am J Hematol. 2001; 68(4): 287-91.
2001
Zent C. "Anemia and chronic disease". US Medicine. 2001; 37(5 Suppl): 5-8.
2001
Zent CS; Kyasa MJ; Evans R; Schichman SA. "Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data". Cancer. 2001; 92(5): 1325-30.
2000 May
Kohli M; Schichman SA; Fink L; Zent CS. "Use of HFE mutation analysis for hereditary hemochromatosis: the need for physician education in the translation of basic science to clinical practice". South Med J. 2000; 93(5): 469-71.
1999 Oct
Govindarajan R, Baxter D, Wilson C, Zent C. "Vancomycin-induced thrombocytopenia." American journal of hematology. 1999 Oct; 62(2):122-3.
1999 May
Zent CS; Ratajczak J; Ratajczak MZ; Anastasi J; Hoffman PC; Gewirtz AM. "Relationship between megakaryoctye mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura". Br J Haematol. 1999; 105(2): 452-8.
1998
Zent CS; Wilson CS; Tricot G; Jagannath S; Siegel D; Desikan KR; Munshi N; Bracy D; Barlogie B; Butch AW. "Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation". Blood. 1998; 91(9): 3518-23.
1997 Apr
Zent C; Rowley JD; Nucifora G. "Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies". Leukemia. 1997; 3(11 Suppl): 273-8.
1996
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G. "Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression nof co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigneic properties". Current Topics in Microbiology & Immunology. 1996; 211: 243-52.
1996
Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G. "The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties". Proc Natl Acad Sci. 1996; 93(3): 1044-8.
1994 May
Zent C, Smith P. "Drug allergy". S AFr Med J. 1994; 84(5): 281-286.
1994
Zent CS. "Toxicity of anti-tuberculous medication". S. Afr J of Epidemiology and Infection. 1994; 9(1): 5-9.
1993 Nov
Zent CS, Allin R, Folb PI. "Prediction of amikacin dose requirements in neutropenic patients with haematological disease". S. Afr Med J. 1993; 82(11): 853-854.

Books

2010
Mauermann ML, Zent CS, Low PA. "Chronic lymphocytic leukemia causing multiple mononeuropathies". Companion to Peripheral Neuropathy: Illustrated Cases and New Developments. Dyck PJ, et.al.. Philadelphia: Saunders/Elsevier, 2010. 253-255
2010
Zent C and Polliack A. "Disorders of the Blood". Textbook of Medicine. Warrel D, Cox T, Firth J. : Oxford, 2010.
1997
Zent CS and Golomb HM. "Treatment options for hairy cell leukemia". Interferons: biological activities and clinical efficacy. Aul C, Schneider W. Berlin: Springer, 1997. 132-138
1996
Zent CS, Larson RA. "Acute leukmia in adults". The Chemotherapy Source Book. Perry MC. Baltimore, MD: Williams and Wilkins, 1996. 1379-1398
1995
Zent CS, Golomb HM. "Hairy Cell Leukemia". Current Therapy in Hematology-Oncology. Brain MC, Carbone PP. St. Louis, MO: Mosby, 1995. 271-274
1995
Zent CS. "Anti-infectives for systemic use". South African National Formulary. Gibbon CJ, Swanepoel CR. Cape Town: MASA, 1995. 224-277